Evaluation of Patients With Known or Suspected Heart Disease - Full Text View

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT00001313

Purpose

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).

Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.

These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.

Condition
Peripheral Artery Disease Coronary Disease Diabetes and Heart Failure Dilated Cardiomyopathy Heart Failure Renal Artery Stenosis Pulmonary Hypertension

Genetics Home Reference related topics: pulmonary arterial hypertension

MedlinePlus related topics: Cardiomyopathy Coronary Artery Disease Heart Diseases Heart Failure High Blood Pressure Pulmonary Hypertension

U.S. FDA Resources

Study Type:

Observational

Official Title:

Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date:

May 1992

Estimated Study Completion Date:

January 2009

Detailed Description:

The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.

Eligibility

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

INCLUSION CRITERIA:

The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:

Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
Cardiomyopathies including congestive phenotypes.
Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
Upper extremity peripheral artery disease.
Diabetes with heart failure.
Pulmonary hypertension.

EXCLUSION CRITERIA:

Pregnancy, for those patients who require catheterization-based diagnostics.

Inability to provide informed consent.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001313

Locations

United States, Maryland
Suburban Hospital
Bethesda, Maryland, United States, 20814
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

More Information

Study ID Numbers:

920189, 92-H-0189

First Received:

November 3, 1999

Last Updated:

January 7, 2009

ClinicalTrials.gov Identifier:

NCT00001313

Health Authority:

United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Cardiac Diagnosis
Chest Pain
Hypertrophic Cardiomyopathy
Coronary Artery Disease
Microvascular Angina

Cardiac Investigation
Follow-up
Heart Disease
Chest Pain
Coronary Artery Disease

Study placed in the following topic categories:

Myocardial Ischemia
Cardiomyopathy, Dilated
Angina Pectoris
Pain
Constriction, Pathologic
Renal Artery Obstruction
Arteriosclerosis
Urologic Diseases
Respiratory Tract Diseases
Cardiomyopathy, Hypertrophic
Kidney Diseases
Dilated cardiomyopathy
Arterial Occlusive Diseases
Heart Failure
Heart Diseases

Diabetes Mellitus
Vascular Diseases
Microvascular Angina
Ischemia
Cardiomyopathies
Chest Pain
Coronary Disease
Hypertrophy
Renal artery stenosis
Hypertension, Pulmonary
Lung Diseases
Cardiomegaly
Coronary Artery Disease
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 09, 2009